STOCK TITAN
  1. Home
  2. News
  3. WST

West Pharmaceutical Services, Inc. - $WST STOCK NEWS

Welcome to our dedicated page for West Pharmaceutical Services news (Ticker: $WST), a resource for investors and traders seeking the latest updates and insights on West Pharmaceutical Services stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect West Pharmaceutical Services's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of West Pharmaceutical Services's position in the market.

News
West to Participate in Upcoming Investor Conferences
Rhea-AI Summary
West Pharmaceutical Services, Inc. will be presenting at the Jefferies Healthcare Conference in London on November 14, 2023, and at the Stephens Annual Investment Conference in Nashville on November 16, 2023. A live audio webcast will be available on the company's website, and replays will be accessible for 90 days after the events.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.07%
Tags
conferences
-
News
West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend
Rhea-AI Summary
West Pharmaceutical Services, Inc. announces Q3 2023 financial results, updates full-year guidance, and declares Q4 dividend
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.57%
Tags
dividends earnings
-
News
West to Attend and Showcase Industry Leadership in Packaging and Containment at CPHI Worldwide Conference
Rhea-AI Summary
West Pharmaceutical Services, Inc. announces participation at CPHI Worldwide to showcase its expertise in packaging and containment. West will share guidance on Annex 1 EU GMP regulations and introduce Corning® Viridian™ Vials, a sustainable product.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.89%
Tags
conferences
News
West to Present on Development of Large Volume Delivery Systems, Self-injection Devices, and Prefillable Syringe Component Expertise at the PDA Conference
Rhea-AI Summary
West Pharmaceutical Services to showcase expertise at PDA Universe of Pre-Filled Syringes and Injection Devices Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.19%
Tags
conferences
-
News
West to Host Third-Quarter 2023 Conference Call
Rhea-AI Summary
West Pharmaceutical Services, Inc. to release Q3 2023 financial results on October 26, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.85%
Tags
conferences
-
News
West to Participate in Upcoming Investor Conference
Rhea-AI Summary
West Pharmaceutical Services, Inc. to present at Bank of America Global Healthcare Conference in London on September 14, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.24%
Tags
conferences
News
West to Participate in Upcoming Investor Conference
Rhea-AI Summary
West Pharmaceutical Services, Inc. (NYSE: WST) to present at UBS MedTech, Tools and Genomics Summit on August 16, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.23%
Tags
conferences
-
News
West Announces Second-Quarter 2023 Results
Rhea-AI Summary
WST: West Pharmaceutical Services, Inc. Announces Q2 2023 Financial Results and Updated Full-Year Guidance. Net sales declined 2.3% to $753.8 million, with a raised full-year 2023 net sales guidance to $2.970 billion to $2.995 billion. Adjusted-diluted EPS of $2.11, compared to $2.47 in the same period last year. The company had solid first-half of 2023 and expects continued stability in near- and long-term demand trends for high-value product components, devices, and systems.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.46%
Tags
earnings
-
News
West to Host Second-Quarter 2023 Conference Call
Rhea-AI Summary
West Pharmaceutical Services, Inc. (NYSE: WST) will release its second-quarter 2023 financial results on July 27, 2023, before the market opens. The company will host a conference call at 9:00 a.m. Eastern Time to discuss the results and business expectations. Participants can register in advance to ask questions to Management. The live audio-only webcast will be available via the Company's Investor Relations website. A slide presentation will be referenced during the call and made available on the day of the call. A replay of the conference call and webcast will be accessible on the Company's website for 30 days, and the webcast will be available for approximately 90 days after the events.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.04%
Tags
conferences
News
West to Participate in Upcoming Investor Conferences
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.63%
Tags
conferences
Stock WST logo
West Pharmaceutical Services, Inc.

NYSE:WST

WST Rankings

#414 Ranked by Market Cap
#521 Ranked by Stock Gains
#2081 Ranked by Dividends

WST Stock Data

26.83B
72.82M
0.56%
95.9%
1.55%
Surgical and Medical Instrument Manufacturing
Manufacturing
Link
United States of America
EXTON

About WST

west works side-by-side with healthcare partners from concept to the patient, designing and manufacturing packaging and delivery systems that promote efficiency, reliability and safety. west leads the way with cutting-edge technologies and quality systems, a thorough understanding of global regulatory compliance, and an unmatched knowledge of relevant pharmaceutical product testing, development and packaging. west supports customers from sales, manufacturing, and research and development locations in north and south america, europe, asia and australia.